Nineteenth Annual Pezcoller Symposium: Hypothesis-driven clinical investigation in cancer

Cancer Research

Volumn 67, Issue 23, 2007, Pages 11102-11105

  Kaelin, William G ^a   Sawyers, Charles L ^b   Mihich, Enrico ^c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DASATINIB; ERLOTINIB; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; GEFITINIB; IMATINIB;

CANCER RELAPSE; CANCER RESEARCH; CANCER SURVIVAL; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; DOWN REGULATION; DRUG EFFICACY; DRUG SENSITIVITY; GENE MUTATION; GLIOBLASTOMA; HUMAN; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

ANIMALS; CLINICAL TRIALS AS TOPIC; DRUG DESIGN; DRUGS, INVESTIGATIONAL; HUMANS; NEOPLASMS;

EID: 37049012898     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-3230     Document Type: Conference Paper

References (0)